1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.
1st Biotherapeutics was founded in 2016 by Jamie Jae Eun Kim.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 156 based in Asia-Pacific (APAC).
1st Biotherapeutics may be growing as it is listed among the leading companies in the HPK1 inhibitor market, which is expected to witness an upsurge in growth by 2032. The company is also actively involved in clinical trials, as evidenced by its initiative to trial a small molecule alongside Keytruda, indicating an expansion in its research and development activities. Being recognized as a key player in a growing market and engaging in new clinical trials are indicators of positive growth for the company.
“At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need.” 1stbio.com
Founded in 2016, 1st Biotherapeutics works in pharmaceutical and therapeutics from Asia-Pacific (APAC) and has 11-50 employees. It has raised $17 billion over 2 rounds and its website drew about 1,290 visits in the latest month measured.
11-50 employees · advancells.com
11-50 employees · absoluterx.com
11-50 employees · agephapharma.com
51-100 employees · acimmune.com
1-10 employees · abbiosciences.com
1-10 employees · 101therapeutics.com
101-250 employees · aclaristx.com
101-250 employees · aveooncology.com
11-50 employees · a-seeds.co.jp
11-50 employees · activeability.com.au
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.